How effective is jelqing or traction devices for penis growth?

Checked on January 24, 2026
Disclaimer: Factually can make mistakes. Please verify important information or breaking news. Learn more.

Executive summary

Jelqing — a manual “milking” technique promoted online — has no high‑quality clinical evidence demonstrating reliable, lasting penis enlargement and is explicitly discouraged by urology societies as unproven and potentially harmful [1] [2]. Penile traction devices have modest, context‑specific evidence of benefit (mainly for Peyronie’s disease or post‑prostatectomy shrinkage) in small trials and some randomized studies, but gains require long hours of use, results vary, and the literature has significant methodological limitations [3] [4] [5] [6].

1. What proponents claim and how the methods work

Jelqing is described as repeated manual strokes on a semi‑erect penis intended to stretch tissue and improve blood flow; proponents argue micro‑trauma leads to tissue expansion, while traction devices apply sustained mechanical pull to induce tissue remodeling over time [2] [7]. Historical and cultural anecdotes about manual stretching exist, but these do not substitute for controlled clinical evidence [8] [9].

2. The evidence (or lack of it) for jelqing

Systematic reviews and mainstream medical reporting conclude there is little to no reliable evidence that jelqing lengthens the penis, and high‑quality randomized controlled trials testing jelqing for size enlargement are effectively absent, leaving most success stories anecdotal [1] [2] [7]. Urology authorities caution that manual techniques like jelqing are unvalidated; therefore any claim of consistent, permanent enlargement from jelqing is unsupported by the peer‑reviewed literature presently cited by medical outlets [1] [2].

3. The evidence for traction (penile extenders): modest, situational gains

Clinical studies and device trials show traction therapy can produce modest, measurable increases in flaccid and stretched length in some cohorts — for example, a preliminary study reported mean flaccid length rising from 8.8 cm to 10.5 cm after months of extender use — and randomized trials of newer devices have demonstrated statistically significant length and erectile function improvements in men with Peyronie’s disease or post‑prostatectomy concerns [3] [4] [6]. However, these studies are often small, nonrandomized, or limited to specific patient groups, and reviewers note selection bias and compliance issues that complicate generalizing results to healthy men seeking cosmetic enlargement [10] [3] [6].

4. Practical constraints, harms and tolerability

Traction protocols reported in trials require many hours per day (commonly several hours to up to 9 hours daily) for months to achieve any change, which poses real adherence challenges, and adverse effects — transient pain, erythema, and compliance‑related reductions in benefit — are reported in trials (penile erythema in ~2% and transient pain in ~25% in one RCT protocol summary) [5] [10]. Jelqing carries documented risks in the literature including fibrosis, plaque formation, and hard‑flaccid syndromes cited by clinicians; aggressive or unregulated stretching can cause tissue damage rather than safe enlargement [9] [2].

5. Interpreting the balance: when results are plausible and when they’re not

For men with penile deformities, scar contracture, or post‑surgical shortening (Peyronie’s disease or post‑prostatectomy), traction therapy has a plausible therapeutic role supported by multiple clinical reports and some randomized evidence, albeit imperfect [10] [4] [6]. For otherwise healthy men seeking cosmetic size increase, the preponderance of authoritative sources — including major urology associations summarized in consumer health outlets — conclude that jelqing is unproven and most non‑surgical methods offer little reliable benefit [1] [2] [9].

6. Conclusion and limits of the reporting

The consistent, evidence‑based verdict is clear: jelqing lacks robust clinical proof and poses measurable risk, while medically supervised penile traction devices can produce modest, durable gains in specific patient populations but demand long daily use and are supported by limited, sometimes biased trials; this synthesis rests on the studies, reviews, and society statements available in the cited sources and cannot adjudicate unpublished data or individual manufacturing claims [1] [3] [10] [6]. Alternative viewpoints exist — small case series and commercial sites claim larger effects — but these are often anecdotal or industry‑aligned and warrant skepticism given methodological shortcomings noted in the literature [8] [11].

Want to dive deeper?
What randomized trials exist comparing different penile traction devices for Peyronie’s disease?
What complications have been reported after unsupervised jelqing in clinical case reports?
How do urology societies (AUA, SMSNA) currently advise clinicians about non‑surgical penis enlargement methods?